Showing results (701-710 of 10,067) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|December 27, 2005
Serum uric acid and risk of coronary heart diseaseS Goya WannametheeCurrent Pharmaceutical Design|December 27, 2005
Uric acid and oxidative stressG K Glantzounis, E C Tsimoyiannis, A M Kappas, et al.Current Pharmaceutical Design|December 27, 2005
Uric acid and the kidney: urate transport, stone disease and progressive renal failureG Capasso, Ph Jaeger, W G Robertson, et al.Current Pharmaceutical Design|December 27, 2005
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemiaS S Daskalopoulou, V Tzovaras, D P Mikhailidis, et al.Current Pharmaceutical Design|December 27, 2005
Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal womenCristiano Maria Francucci, Andrea Camilletti, Marco BoscaroCurrent Pharmaceutical Design|December 27, 2005
Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor XaA Kranjc, D Kikelj, L Peterlin-MasicCurrent Pharmaceutical Design|December 27, 2005
Lifelong endocrine fluctuations and related cognitive disordersM L Ancelin, K RitchieCurrent Pharmaceutical Design|December 28, 2005
Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterasesAllen D SeftelCurrent Pharmaceutical Design|December 28, 2005
Endothelial nitric oxide synthase gene therapy for erectile dysfunctionTrinity J Bivalacqua, Biljana Musicki, Mustafa F Usta, et al.Current Pharmaceutical Design|February 20, 2010
Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis?Jeroen T Buijs, Maj Petersen, Geertje van der Horst, et al.Pageof 1,007